Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure

Patients with chronic heart failure (HF) are at increased risk of both fatal and nonfatal major adverse cardiovascular events. We used data from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) trials to assess the influence of nonfatal hospitalizations fo...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Circulation (New York, N.Y.) Ročník 116; číslo 13; s. 1482
Hlavní autoři:	Solomon, Scott D, Dobson, Joanna, Pocock, Stuart, Skali, Hicham, McMurray, John J V, Granger, Christopher B, Yusuf, Salim, Swedberg, Karl, Young, James B, Michelson, Eric L, Pfeffer, Marc A
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 25.09.2007
Témata:	Aftercare Aged Aged, 80 and over Angiotensin II Type 1 Receptor Blockers - therapeutic use Benzimidazoles - therapeutic use Death, Sudden, Cardiac - epidemiology Disease Progression Female Follow-Up Studies Heart Failure - drug therapy Heart Failure - mortality Hospitalization - statistics & numerical data Humans Male Middle Aged Proportional Hazards Models Randomized Controlled Trials as Topic - statistics & numerical data Survival Analysis Tetrazoles - therapeutic use
ISSN:	1524-4539, 1524-4539
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!